Close
Nordic 9Nordic 9

Weatherden (investor - Others)

United Kingdom weatherden.co.uk
See something wrong or missing? Let us know
Offices:London

Weatherden is a British integrated clinical consultancy and experts in scientific strategy and clinical development that is trusted by biopharma, funds, startups, spin-outs and nonprofits.

Average round investment:70M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: United Kingdom Elevara Medicines
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Weatherden

Name Criteria
United States Vivo Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Integrated
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adage Capital Management
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Negev Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Intuitive Ventures
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Alex Gorsky
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States MPM Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Merifin Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Brace Pharma Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top